Total Payments
$2,220
2023 Payments
$233.13
Companies
26
Transactions
93
Medicare Patients
8,180
Medicare Billing
$689,980
Payment Breakdown by Category
Food & Beverage$2,040 (91.9%)
Education$180.10 (8.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,040 | 88 | 91.9% |
| Education | $180.10 | 5 | 8.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $473.46 | 26 | $0 (2022) |
| Janssen Biotech, Inc. | $226.31 | 13 | $0 (2023) |
| PFIZER INC. | $223.14 | 13 | $0 (2023) |
| Axonics Modulation Technologies, Inc. | $158.83 | 3 | $0 (2020) |
| NeoTract Inc. | $126.42 | 1 | $0 (2017) |
| Ferring Pharmaceuticals Inc. | $125.00 | 1 | $0 (2017) |
| Janssen Scientific Affairs, LLC | $112.72 | 1 | $0 (2018) |
| TOLMAR Pharmaceuticals, Inc. | $105.79 | 5 | $0 (2022) |
| Blue Earth Diagnostics Limited | $76.66 | 2 | $0 (2021) |
| Boston Scientific Corporation | $70.25 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $233.13 | 10 | Boston Scientific Corporation ($70.25) |
| 2022 | $268.68 | 13 | TOLMAR Pharmaceuticals, Inc. ($90.71) |
| 2021 | $386.12 | 19 | Astellas Pharma US Inc ($140.34) |
| 2020 | $339.90 | 14 | Axonics Modulation Technologies, Inc. ($158.83) |
| 2019 | $307.50 | 12 | Astellas Pharma US Inc ($210.09) |
| 2018 | $259.24 | 7 | Janssen Scientific Affairs, LLC ($112.72) |
| 2017 | $425.61 | 18 | NeoTract Inc. ($126.42) |
All Payment Transactions
93 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/24/2023 | Boston Scientific Corporation | WATCHMAN Access System (Device) | Food and Beverage | In-kind items and services | $51.39 | General |
| Category: WATCHMAN_IC | ||||||
| 08/14/2023 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: Oncology | ||||||
| 07/28/2023 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: Oncology | ||||||
| 05/12/2023 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $29.77 | General |
| Category: Oncology | ||||||
| 05/05/2023 | Boston Scientific Corporation | LithoVue (Device) | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: LithoVue_URO | ||||||
| 04/13/2023 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $25.36 | General |
| Category: Oncology | ||||||
| 03/31/2023 | PFIZER INC. | XTANDI (Drug), ORGOVYX, COMIRNATY | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: ONCOLOGY | ||||||
| 03/23/2023 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: Oncology | ||||||
| 01/27/2023 | PFIZER INC. | XTANDI (Drug), ORGOVYX, COMIRNATY | Food and Beverage | In-kind items and services | $25.47 | General |
| Category: ONCOLOGY | ||||||
| 01/13/2023 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: Oncology | ||||||
| 12/06/2022 | Antares Pharma, Inc. | XYOSTED (Drug), TLANDO, NOCDURNA | Food and Beverage | In-kind items and services | $22.58 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 11/18/2022 | Accord Healthcare, Inc. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $22.21 | General |
| Category: Oncology | ||||||
| 11/04/2022 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: Oncology | ||||||
| 10/21/2022 | UroGen Pharma, Inc. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $25.18 | General |
| Category: UROTHELIAL CANCER | ||||||
| 10/07/2022 | TOLMAR Pharmaceuticals, Inc. | ELIGARD (Drug) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: Prostate Cancer | ||||||
| 08/05/2022 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA, WELIREG | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: ONCOLOGY | ||||||
| 07/15/2022 | GENZYME CORPORATION | JEVTANA (Drug) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: Oncology | ||||||
| 06/24/2022 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $18.57 | General |
| 06/11/2022 | Coloplast Corp | SpeediCath (Device) | Food and Beverage | In-kind items and services | $23.90 | General |
| Category: Continence Care | ||||||
| 06/03/2022 | TOLMAR Pharmaceuticals, Inc. | ELIGARD (Drug) | Education | In-kind items and services | $25.50 | General |
| Category: Prostate Cancer | ||||||
| 06/03/2022 | TOLMAR Pharmaceuticals, Inc. | ELIGARD (Drug) | Food and Beverage | In-kind items and services | $23.25 | General |
| Category: Prostate Cancer | ||||||
| 03/31/2022 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: Oncology | ||||||
| 02/25/2022 | TOLMAR Pharmaceuticals, Inc. | ELIGARD (Drug) | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: Prostate Cancer | ||||||
| 11/19/2021 | DENTSPLY IH Inc. | LoFric (Device) | Food and Beverage | In-kind items and services | $22.58 | General |
| Category: Medical Urology | ||||||
| 10/14/2021 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $23.26 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 2,104 | 3,387 | $643,937 | $197,061 |
| 2022 | 20 | 1,841 | 2,915 | $527,580 | $159,936 |
| 2021 | 26 | 2,109 | 3,369 | $567,619 | $172,410 |
| 2020 | 20 | 2,126 | 3,251 | $537,869 | $160,572 |
Total Patients
8,180
Total Services
12,922
Medicare Billing
$689,980
Procedure Codes
94
All Medicare Procedures & Services
94 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 273 | 446 | $142,720 | $41,330 | 29.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 262 | 357 | $81,039 | $23,069 | 28.5% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 99 | 129 | $78,690 | $22,559 | 28.7% |
| 50590 | Shock wave crushing of kidney stones | Facility | 2023 | 34 | 45 | $65,700 | $20,968 | 31.9% |
| 52601 | Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | Facility | 2023 | 30 | 30 | $55,980 | $17,574 | 31.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 106 | 106 | $44,732 | $12,629 | 28.2% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 16 | 79 | $26,544 | $10,661 | 40.2% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 95 | 243 | $23,814 | $9,863 | 41.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 54 | 56 | $19,096 | $5,777 | 30.3% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 67 | 68 | $17,408 | $4,626 | 26.6% |
| 52310 | Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | Office | 2023 | 18 | 18 | $14,562 | $4,564 | 31.3% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 18 | 86 | $13,674 | $4,190 | 30.6% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 29 | 31 | $12,276 | $3,704 | 30.2% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 18 | 18 | $11,016 | $3,231 | 29.3% |
| 81003 | Automated urinalysis test | Office | 2023 | 513 | 1,061 | $5,305 | $2,330 | 43.9% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 44 | 50 | $5,250 | $2,063 | 39.3% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 18 | 18 | $6,174 | $1,914 | 31.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 159 | 256 | $1,536 | $1,505 | 98.0% |
| 51701 | Insertion of temporary bladder tube | Office | 2023 | 28 | 33 | $3,762 | $999.97 | 26.6% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 15 | 15 | $3,105 | $981.75 | 31.6% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 111 | 130 | $3,380 | $957.73 | 28.3% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 16 | 26 | $2,106 | $633.84 | 30.1% |
| 74420 | Imaging of urinary tract following injection of a contrast agent | Facility | 2023 | 29 | 31 | $5,270 | $605.43 | 11.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 18 | 18 | $630.00 | $178.40 | 28.3% |
| P9612 | Catheterization for collection of specimen, single patient, all places of service | Office | 2023 | 16 | 19 | $114.00 | $111.72 | 98.0% |
About Dr. Robert Youngman, MD
Dr. Robert Youngman, MD is a Urology healthcare provider based in New Smyrna Beach, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1609827567.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Youngman, MD has received a total of $2,220 in payments from pharmaceutical and medical device companies, with $233.13 received in 2023. These payments were reported across 93 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($2,040).
As a Medicare-enrolled provider, Youngman has provided services to 8,180 Medicare beneficiaries, totaling 12,922 services with total Medicare billing of $689,980. Data is available for 4 years (2020–2023), covering 94 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location New Smyrna Beach, FL
- Active Since 05/15/2006
- Last Updated 02/11/2021
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1609827567
Products in Payments
- XTANDI (Drug) $402.14
- Erleada (Drug) $170.05
- Axonics r-SNM System (Device) $158.83
- ERLEADA (Drug) $153.26
- Urolift - UL400 (Device) $126.42
- FIRMAGON (Drug) $125.00
- Myrbetriq (Drug) $106.48
- ELIGARD (Drug) $105.79
- Axumin (Drug) $76.66
- JEVTANA (Drug) $57.50
- WATCHMAN Access System (Device) $51.39
- PLUVICTO (Drug) $49.63
- CAMCEVI (Drug) $47.57
- Nubeqa (Drug) $44.95
- VESICARE (Drug) $36.44
- TITAN (Device) $35.35
- MYRBETRIQ (Drug) $31.93
- JELMYTO (Drug) $25.18
- SpeediCath (Device) $23.90
- BOTOX (Biological) $23.31
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.